Methyl 2-(5-methoxy-1H-indol-3-yl)acetate

Catalog No. :
ACTSLZ590
CAS No. :
23304-48-5
Molecular Formula :
C12H13NO3
Molecular Weight :
219.24

IUPAC Name:methyl 2-(5-methoxy-1H-indol-3-yl)acetate

Methyl 2-(5-methoxy-1H-indol-3-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$358.00Login to see priceInquiryInquiry
1g95%$897.00Login to see priceInquiryInquiry
5g95%$2693.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(5-methoxy-1H-indol-3-yl)acetate
IUPAC Namemethyl 2-(5-methoxy-1H-indol-3-yl)acetate
MDL No.MFCD15527683
Molecular FormulaC12H13NO3
Molecular Weight219.24
SMILESCOC(C=C12)=CC=C2NC=C1CC(OC)=O
InChI KeyUZOYTCVZJBYXIA-UHFFFAOYSA-N
Synonym5-Methoxy-1H-indole-3-acetic acid methyl ester;1H-Indole-3-acetic acid, 5-Methoxy-, Methyl ester;methyl 2-(5-methoxy-1H-indol-3-yl)acetate;Methyl 5-Methoxyindole-3-acetate;methyl (5-methoxy-1H-indol-3-yl)acetate
CAS No.23304-48-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTSLZ590 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACERPA031 route compound structure diagram
    ACERPA0313471-31-6 In Stock
  4. Then
  5. ACTSLZ590 route product structure diagram
    ACTSLZ59023304-48-5
Inquiry

2. ACTSLZ590 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACERPA031 route compound structure diagram
    ACERPA0313471-31-6 In Stock
  4. Then
  5. ACTSLZ590 route product structure diagram
    ACTSLZ59023304-48-5
Inquiry

Comments (0)